VEGFA and neoplasm: As shown in Figure 13, BIC201 given six times, once weekly i.p. at doses of 10 or 20 mg/kg inhibited tumor growth significantly more than bevacizumab (which corresponds to the anti VEGF arm of BIC201) given at 10 mg/kg.